United States · FDA National Drug Code directory
NYSTATIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17856-0508_484acdef-5f40-bd3e-e063-6394a90aebe2
- Product NDC
- 17856-0508
- Form
- SUSPENSION
- Composition / generic term
- NYSTATIN
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221205
- Source listing expiry
- 20271231
Source-listed ingredients
- NYSTATIN — 100000 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0508-1) / 5 mL in 1 CUP, UNIT-DOSE · 17856-0508-1
- 48 SYRINGE in 1 BOX, UNIT-DOSE (17856-0508-3) / 5 mL in 1 SYRINGE · 17856-0508-3
- 48 SYRINGE in 1 BOX, UNIT-DOSE (17856-0508-5) / 5 mL in 1 SYRINGE · 17856-0508-5
- 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0508-7) / 1 mL in 1 SYRINGE · 17856-0508-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →